Onconova Therapeutics, Inc. Reports Business Highlights and First Quarter 2019 Financial Results

    NEXT STORY
    resTORbio Appoints Lloyd Klickstein, M.D., Ph.D., as Chief Scientific Officer
    PREV STORY
    Myriad Genetics to Present Multiple Studies at the 2019 American Society of Clinical Oncology Annual Meeting
    Subscribe to PM360
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    Three-Year Follow-Up Data From Lombard Medical Aorfix(TM) PYTHAGORAS Pivotal Trial Presented at 42nd Annual VEITHsymposium(TM)

    IRVINE, Calif., Nov. 30, 2015 (GLOBE NEWSWIRE) -- Lombard Medical, Inc. (NASDAQ:EVAR), a medical ...

    author_avatar
    NASDAQ Market News

    Lynparza Granted BTD in US for Prostate Cancer

    LYNPARZA™ (Olaparib) granted Breakthrough Therapy Designation by US FDA for treatment of BRCA1/2 or ...

    author_avatar
    NASDAQ Market News

    RedHill Biopharma Provides Q1/2020 Financial Results and Recent Highlights Including Initial Movantik® Revenues

    author_avatar
    NASDAQ Market News